Human PGFM(13,14 dihydro 15 keto Prostaglandin F2 Alpha) EIA Kit

Human PGFM(13,14 dihydro 15 keto Prostaglandin F2 Alpha) EIA Kit

Size

96Test

Catalog no.

E-EL-H5318-96T

Price

492 EUR

Buy

UNIProt ID

NA

Target Synonym

NA

Target Name

PGFM

Target Species

Human

Sensitivity

0.19ng/mL

Type

Competitive

Detection Type

Colormetric

Detection Range

0.31~20ng/mL

Tested Sample Types

Serum, Plasma, Cell supernatant

Product Name

Human PGFM(13,14 dihydro 15 keto Prostaglandin F2 Alpha) EIA Kit

Description

The PGFM(13,14 dihydro 15 keto Prostaglandin F2 Alpha) EIA Kit is a α- or alpha protein sometimes glycoprotein present in blood.This ELISA test kit or EIA Enzyme immuno assay is an enzyme linked immuno assay supplied as coated 96 well plates with antigen or antibody and needs to be stored at +4°C.

Properties

MeSH E05 478 566 350 170 Enzyme-Linked Immunosorbent Assay,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Test principle

This EIA kit uses the Competitive-EIA principle. The micro EIA plate provided in this kit has been pre-coated with Human PGFM. During the reaction, Human PGFM in the sample or standard competes with a fixed amount of Human PGFM on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human PGFM. Excess conjugate and unbound sample or standard are washed from the plate, and Avidin conjugated to Horseradish Peroxidase (HRP) are added to each microplate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human PGFM in the samples is then determined by comparing the OD of the samples to the standard curve.